{"id":"NCT01751126","sponsor":"Santen SAS","briefTitle":"Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis","officialTitle":"A Multicenter, Randomized, Double-Masked, 3 Parallel Arms, Placebo Controlled Study to Assess the Efficacy and Safety of NOVA22007 1mg/mL (Ciclosporin/Cyclosporine) Eye Drops, Emulsion Administered in Paediatric Patients With Active Severe Vernal Keratoconjunctivitis With Severe Keratitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-04-29","primaryCompletion":"2016-02","completion":"2016-02","firstPosted":"2012-12-17","resultsPosted":"2022-03-28","lastUpdate":"2022-03-28"},"enrollment":169,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Vernal Keratoconjunctivitis"],"interventions":[{"type":"DRUG","name":"NOVA22007 ''Ciclosporin''","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ciclosporin","type":"EXPERIMENTAL"},{"label":"Ciclosporin/Placebo","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to compare the efficacy of two different dosing regimen of NOVA22007 (1mg/ml ciclosporin/cyclosporine) eye drops, emulsion versus placebo (vehicle of the formulation) administered four times a day in patients with severe vernal keratoconjunctivitis after 4 months of treatment.","primaryOutcome":{"measure":"Average Penalties Adjusted Composite Efficacy Score (CFS) Score Over the 4 Months","timeFrame":"over the 4 months","effectByArm":[{"arm":"High Dose Regimen","deltaMin":2.06,"sd":1.44},{"arm":"Low Dose Regimen","deltaMin":1.93,"sd":1.37},{"arm":"Placebo","deltaMin":1.34,"sd":1.22}],"pValues":[{"comp":"OG000 vs OG002","p":"0.007"},{"comp":"OG001 vs OG002","p":"0.010"}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":46,"countries":["United States","Croatia","France","Germany","Greece","Hungary","India","Israel","Italy","Portugal","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":50},"commonTop":["Instillation site pain","Nasopharyngitis","Instillation site pruritus","Headache","Ocular hyperaemia"]}}